Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs-Reference-Cited by-同舟云学术

Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs

Published:2014-06-10 Issue: Volume:5 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Godman Brian,MalmstrÃ¶m Rickard E.,Diogene Eduardo,Jayathissa Sisira,McTaggart Stuart,Cars Thomas,Alvarez-Madrazo Samantha,BaumgÃ¤rtel Christoph,Brzezinska Anna,Bucsics Anna,Campbell Stephen,Eriksson Irene,Finlayson Alexander,FÃ¼rst Jurij,Garuoliene Kristina,GutiÃ©rrez-Ibarluzea IÃ±aki,Hviding Krystyna,Herholz Harald,Joppi Roberta,Kalaba Marija,Laius Ott,Malinowska Kamila,Pedersen Hanne B.,Markovic-Pekovic Vanda,Piessnegger Jutta,Selke Gisbert,Sermet Catherine,Spillane Susan,Tomek Dominik,VonÄina Luka,VlahoviÄ‡-PalÄevski Vera,Wale Janet,Wladysiuk Magdalena,van Woerkom Menno,Zara Corinne,Gustafsson Lars L.

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference1 articles.

1. Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers;Adamski;BMC Health Serv. Res,2010

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adoption of new therapies in the treatment of Hepatitis: a verification of the accuracy of budget impact analysis to guide investment decisions;Expert Review of Pharmacoeconomics & Outcomes Research;2022-04-04

2. Global access to affordable direct oral anticoagulants;Bulletin of the World Health Organization;2021-09-01

3. Structural Changes of Sodium Warfarin in Tablets Affecting the Dissolution Profiles and Potential Safety of Generic Substitution;Pharmaceutics;2021-08-30

4. Evidence-based public policy making for medicines across countries: findings and implications for the future;Journal of Comparative Effectiveness Research;2021-08

5. Variation in the prices of oncology medicines across Europe and the implications for the future;Generics and Biosimilars Initiative Journal;2021-06-15